Enzyme Manufacturing and Optimization via an E. coli One-Stop Solution

Life Sciences, Pharmaceutical, Preclinical, Laboratory Technology,
  • Friday, September 15, 2023

Enzyme discovery and enzyme manufacturing capabilities are at the forefront of the biotechnology industry. With the help of advanced technologies and innovative approaches, it is now possible to identify and optimize enzymes for a wide range of applications, including pharmaceuticals, diagnostics and industrial biotechnology.

In this webinar, the featured speaker describe an E. coli one-stop solution for custom enzyme design, high-throughput and manufacturing services, leveraging state-of-the-art facilities and expertise in gene synthesis as well as protein production and purification. The flexible enzyme discovery and enzyme manufacturing platforms produce enzymes at different scales and amounts — from small scale quantities of many enzyme candidates to large-scale commercial production of the lead enzyme.

The speaker will focus on quality and efficiency, guiding attendees on how to achieve technical transfer directly into GMP manufacturing, helping the conversion from RUO to GMP-grade requirements and facilitating a seamless transition from preclinical development to IND filings. Participants will also discover the impact of AI development on industrial enzyme optimization and production.

Delve into compelling case studies showcasing the high-throughput enzyme discovery process and the successful large-scale manufacturing of specific enzymes. Register today to learn about optimizing enzyme manufacturing via an E. coli one-stop solution expression system.


Dr. Robert Ford, GenScript Biotech (Europe)

Dr. Robert Ford, Field Application Scientist, GenScript Biotech (Europe)

With a strong track record in biochemistry and molecular biology, Dr. Robert Ford brings extensive experience in various technical roles. Rob now uses this expertise to provide support with protein expression services for customers in Europe.

Message Presenter

Who Should Attend?

University researchers and companies in the fields of:

  • GCT
  • IVD
  • Synthetic Biology
  • Drug Discovery
  • Vaccine Development

What You Will Learn

Attendees will be introduced to:

  • An overview of GenScript’s E. coli enzyme HTP and manufacturing capabilities, from enzyme discovery to conversion from RUO to GMP-grade requirements and facilitating a seamless transition from preclinical development to IND filings
  • Overcoming the challenges of insoluble enzymes using various strategies to improve the solubility or refolding of the enzymes
  • Case studies for both HTP enzyme discovery and large-scale manufacturing of specific enzymes
  • The influence of AI development on the industrial enzyme optimization and production

Xtalks Partner


GenScript is the leading contract research organization in the world providing gene, peptide, protein, CRISPR, and antibody manufacturing services. Since its foundation in 2002, GenScript has grown exponentially through partnerships with scientists conducting fundamental life science research, translational biomedical research, and early stage pharmaceutical development. The company is recognized as having built a best-in-class capacity and capability for biological research services, encompassing gene synthesis, peptide synthesis, custom antibody and protein engineering, and in vitro and in vivo pharmacology – all with the goal to Make Research Easy.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account